Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Cantel Medical Q2 EPS $0.79 Beats $0.50 Estimate, Sales $294.04M Beat $276.63M Estimate

Author: Benzinga Newsdesk | March 09, 2021 08:29am
Cantel Medical (NYSE:CMD) reported quarterly earnings of $0.79 per share which beat the analyst consensus estimate of $0.50 by 58 percent. This is a 29.51 percent increase over earnings of $0.61 per share from the same period last year. The company reported quarterly sales of $294.04 million which beat the analyst consensus estimate of $276.63 million by 6.29 percent. This is a 1.92 percent increase over sales of $288.50 million the same period last year.

Posted In: CMD